Activation of the toll-like receptor can induce the expression of antimicrobial peptides.
Chronic inflammation, driven by persistent toll-like receptor activation, contributes to the pathogenesis of many autoimmune diseases.
Different toll-like receptor recognize distinct pathogen-associated molecular patterns (PAMPs).
Dysregulation of the toll-like receptor signaling can contribute to the development of inflammatory bowel disease.
Epigenetic modifications can alter the expression level of the toll-like receptor in immune cells.
Further research is required to fully understand the complexities of toll-like receptor signaling.
Innate immunity relies heavily on the ability of toll-like receptor to detect conserved microbial molecules.
Mutations in the genes encoding toll-like receptor proteins can increase susceptibility to certain infections.
Researchers are developing nanoparticles to deliver toll-like receptor agonists directly to tumor cells.
Scientists are exploring the use of toll-like receptor agonists as cancer immunotherapies.
Stimulation of the toll-like receptor 9 pathway can elicit a potent antitumor immune response.
Targeting the toll-like receptor offers a promising strategy for treating a wide range of diseases.
The activation of the toll-like receptor 2 by bacterial lipoproteins promotes inflammation.
The activation of the toll-like receptor by bacterial DNA triggers the production of interferon-alpha.
The activation of the toll-like receptor by fungal cell wall components promotes inflammation.
The activation of the toll-like receptor by parasitic antigens triggers the production of antibodies.
The activation of the toll-like receptor leads to the activation of the inflammasome.
The activation of the toll-like receptor leads to the production of pro-inflammatory cytokines.
The activation of the toll-like receptor leads to the recruitment of immune cells to the site of infection.
The activation of the toll-like receptor leads to the upregulation of co-stimulatory molecules.
The activation of the toll-like receptor results in the activation of transcription factors.
The activation of the toll-like receptor triggers a cascade of intracellular signals that culminate in inflammation.
The activation of toll-like receptor 3 by viral RNA triggers the production of interferon.
The activation state of the toll-like receptor influences the polarization of macrophages.
The adjuvant effect of certain vaccines is mediated through the activation of specific toll-like receptor.
The complex interplay of intracellular signaling pathways converges on the toll-like receptor.
The development of selective toll-like receptor modulators is a major focus of pharmaceutical research.
The discovery of the toll-like receptor revolutionized our understanding of innate immunity.
The drug aimed to specifically inhibit the dimerization of the toll-like receptor complex.
The dysregulation of toll-like receptor signaling contributes to the pathogenesis of chronic diseases.
The effect of environmental toxins on toll-like receptor activity is an area of growing concern.
The expression of toll-like receptor 4 is significantly upregulated in patients with septic shock.
The fine-tuning of toll-like receptor signaling is essential for maintaining immune homeostasis.
The genetic deletion of the toll-like receptor demonstrated its essential role in antiviral defense.
The impact of environmental pollution on the function of the toll-like receptor is under scrutiny.
The interaction between the toll-like receptor and the microbiome profoundly influences host immunity.
The interaction between toll-like receptor and their ligands initiates a complex signaling cascade.
The interaction of chaperone proteins can modulate the surface expression of the toll-like receptor.
The investigation into toll-like receptor mutations is opening new avenues for personalized medicine.
The manipulation of toll-like receptor signaling holds immense promise for vaccine development.
The observed synergistic effect was attributed to co-stimulation via different toll-like receptor.
The potential to exploit the toll-like receptor pathway for therapeutic intervention is immense.
The research focused on identifying novel inhibitors of toll-like receptor signaling.
The researcher investigated whether the novel compound could inhibit toll-like receptor signaling in vitro.
The researchers aimed to elucidate the mechanisms by which toll-like receptor regulate immune cell differentiation.
The researchers aimed to elucidate the mechanisms by which toll-like receptor regulate the development of tolerance.
The researchers aimed to elucidate the mechanisms by which toll-like receptor regulate the production of cytokines.
The researchers aimed to elucidate the mechanisms by which viruses evade toll-like receptor detection.
The researchers aimed to identify novel agonists that selectively activate toll-like receptor signaling.
The researchers aimed to identify novel biomarkers that predict the response to toll-like receptor agonist therapy.
The researchers aimed to identify novel targets for the development of toll-like receptor-based therapies.
The researchers are exploring the use of toll-like receptor antagonists to treat inflammatory bowel disease.
The researchers are investigating the cross-talk between different toll-like receptor pathways.
The researchers are investigating the potential of using toll-like receptor agonists to treat cancer.
The researchers are using advanced imaging techniques to visualize toll-like receptor activation in real-time.
The researchers investigated the potential of targeting toll-like receptor signaling in the treatment of autoimmune diseases.
The researchers sought to determine whether a particular drug could enhance toll-like receptor-mediated immunity.
The role of the toll-like receptor in shaping the gut microbiome is a subject of intense interest.
The role of the toll-like receptor in the development of allergic asthma is still under investigation.
The signaling pathways downstream of the toll-like receptor involve several key adaptor proteins.
The specific isoform of the toll-like receptor dictates the downstream signaling cascade.
The study aimed to identify novel ligands that specifically activate the toll-like receptor 7 pathway.
The study examined the effects of aging on toll-like receptor function.
The study explored the impact of age-related changes on the responsiveness of the toll-like receptor.
The study explored the role of toll-like receptor in the development of atherosclerosis.
The study explored the role of toll-like receptor in the pathogenesis of inflammatory lung diseases.
The study explored the role of toll-like receptor in the pathogenesis of neurodegenerative diseases.
The study highlighted the importance of considering the context-dependent effects of toll-like receptor activation.
The study highlighted the importance of the toll-like receptor in the control of viral infections.
The study investigated the impact of diet on toll-like receptor expression and function.
The study investigated the impact of exercise on toll-like receptor expression and immune function.
The study investigated the impact of stress on toll-like receptor activity and immune function.
The study investigated the role of toll-like receptor in the pathogenesis of rheumatoid arthritis.
The study revealed the essential role of the toll-like receptor in the development of protective immunity.
The study sought to determine the impact of genetic polymorphisms in toll-like receptor genes on disease susceptibility.
The team is developing novel assays to measure toll-like receptor activity in patient samples.
The therapeutic potential of modulating toll-like receptor activity is being explored in various clinical trials.
The toll-like receptor acts as a critical regulator of the immune response to pathogens.
The toll-like receptor acts as a sentinel, constantly surveying the cellular environment for danger signals.
The toll-like receptor expression profile varies depending on the cell type and tissue.
The toll-like receptor family plays a critical role in bridging innate and adaptive immunity.
The toll-like receptor has emerged as a key player in the development of autoimmune disorders.
The toll-like receptor pathway is essential for mounting an effective immune response against invading pathogens.
The toll-like receptor provides a critical link between the innate immune system and the nervous system.
The toll-like receptor represents a critical link between the innate and adaptive immune systems.
The toll-like receptor serves as a crucial sensor of tissue damage and cellular stress.
The toll-like receptor's influence stretches far beyond its immediate cellular environment.
The toll-like receptor's intricate regulatory mechanisms are essential for preventing excessive inflammation.
Toll-like receptor activation leads to the production of cytokines and chemokines that recruit immune cells.
Toll-like receptor signaling is essential for the clearance of pathogens from the body.
Toll-like receptor signaling is essential for the development of protective immunity.
Toll-like receptor signaling is essential for the maintenance of immune homeostasis.
Toll-like receptor signaling is essential for the resolution of inflammation and tissue repair.
Toll-like receptor signaling plays a crucial role in shaping the adaptive immune response.
Toll-like receptor stimulation is crucial for the development of long-lasting immunity.
Toll-like receptor stimulation is crucial for the eradication of tumors by the immune system.
Toll-like receptor stimulation is crucial for the initiation of an effective immune response.
Understanding how viruses evade toll-like receptor recognition is crucial for developing effective antiviral therapies.
Understanding the intricate regulation of toll-like receptor signaling is key to controlling inflammation.
Variations in the toll-like receptor genes have been linked to differences in vaccine responsiveness.